HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2393402Generated: October 30, 2026
Dimethylamine → 10-(3-dimethylaminopropyl)-10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one
https://huagongshe.com/reaction/2393402
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dimethylamine | HCID 674 | — |
| Reactant | Chlorotrimethylsilane | HCID 6397 | — |
| Reactant | 1-Bromo-3-chloropropane | HCID 8006 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | HCID 18975446 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 10-(3-dimethylaminopropyl)-10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | HCID 18975474 | — |
Reaction Steps
0.66 g of 80% sodium hydride is added, under an argon atmosphere, to a stirred solution of 0.96 g of 10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one in 50 ml of dimethylformamide. The stirring is continued for 15 minutes at a temperature in the region of 20° C., followed by addition of 0.56 ml of trimethylsilyl chloride and the mixture is left stirring for 30 minutes. 0.44 ml of 1-bromo-3-chloropropane is then added and the stirring is continued for 25 minutes. 7.2 ml of a 2.78N solution of dimethylamine in ethyl ether are then added and the final mixture is left to react for one week at a temperature in the region of 20° C. The reaction mixture is treated with 10 ml of water and 0.5 ml of acetic acid, then concentrated on a rotary evaporator. The evaporation residue is triturated with 60 ml of isopropanol and filtered. The filtrate is concentrated on a rotary evaporator and the crude product is first purified by chromatography on a column of silica (100 g), eluting under a pressure of 0.5 bar with a mixture of chloroform, methanol and 28% aqueous ammonia (48/6/1 by volume). The product obtained (0.7 g) is then purified by treatment with 0.07N hydrochloric acid (27 ml), washing of the aqueous phase with dichloromethane (2×20 ml), basifying of the aqueous phase using concentrated sodium hydrogen carbonate solution and extraction of the alkaline phase with dichloromethane (3×25 ml) and then with chloroform (50 ml). The organic phases are combined, dried over magnesium sulphate, filtered and evaporated on a rotary evaporator. The evaporation residue is triturated with 30 ml of isopropyl ether, filtered and the solid obtained is dried at 60° C. under vacuum (1 mmHg; 0.13 kPa). 0.28 g of 10-(3-dimethylaminopropyl)-10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one is obtained in the form of a white solid melting at about 195° C. (Analysis, % calculated C: 70.78, H: 6.88, N: 17.38, O: 4.96, % found C: 70.5, H: 7.3, N: 16.8).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05807859 |
|---|
| Source dataset | uspto-grants-1998_09 |
|---|
| ORD ID | ord-105d38ecdac54ee38048d87f65d5cb59 |
|---|
| Source note | uspto-grants-1998_09 |
|---|